PCVX

Vaxcyte (PCVX)

About Vaxcyte (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$36.63

Daily low

$31.58

Price at open

$32.08

52 Week High

$121.06

52 Week Low

$27.66

Market cap

4.1B

Dividend yield

0.00%

Volume

4.4M

Avg. volume

2.2M

P/E ratio

-7.88

Vaxcyte News